Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti–PD-1 Therapies in Metastatic MelanomaDouglas B. Johnson, Naveen Dakappagari, Elizabeth Gaughan et al.|Clinical Cancer Research|2018Cited by 176
Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profilingPeter J. Siska, Douglas B. Johnson, Romany Johnpulle et al.|OncoImmunology|2017Cited by 83
Abstract 853: Novel quantitative multiplexed PD-1/PD-L1 immunohistochemistry test provides superior prediction of treatment response in melanoma patientsJennifer Bordeaux, Naveen Dakappagari, Douglas B. Johnson et al.|Cancer Research|2016Cited by 2
Quantitative spatial profiling of PD-1/PD-L1 interaction and HLA-DR/IDO1 to predict outcomes to anti-PD-1 in metastatic melanoma (MM).Douglas B. Johnson, Jennifer Bordeaux, Ju‐Young Kim et al.|Journal of Clinical Oncology|2017Cited by 2
47 Pathologists enhance interpretation of automated multiplex immunohistochemistry assays in cancer immunotherapy trialsEmmanuel Pacia, Naveen Dakappagari, Xun Li et al.|Regular and Young Investigator Award Abstracts|2020Cited by 0